Table 4. Signature Overlap Among Scenarios and Signatures That Distinguished Non–Single Cell Lung Cancer (NSCLC) From Single Cell Lung Cancer (SCLC) Tumorsa.
MicroRNA | Scenario 1 | Scenario 2 | Scenario 3 | NSCLC vs SCLC | Sum |
---|---|---|---|---|---|
miR-1285-3p | x | x | x | 3 | |
miR-205-5p | x | x | x | 3 | |
miR-1260a | x | x | 2 | ||
miR-1260b | x | x | 2 | ||
miR-3152-3p | x | x | 2 | ||
miR-378b | x | x | 2 | ||
miR-17-3p | x | x | 2 | ||
miR-1202 | x | x | 2 | ||
miR-139-5p | x | 1 | |||
miR-16-2-3p | x | 1 | |||
miR-18a-3p | x | 1 | |||
miR-23b-3p | x | 1 | |||
miR-3907 | x | 1 | |||
miR-551b-3p | x | 1 | |||
miR-93-3p | x | 1 | |||
miR-564 | x | 1 | |||
miR-374b-5p | x | 1 | |||
let-7g-3p | x | 1 | |||
miR-193a-5p | x | 1 | |||
miR-21-3p | x | 1 | |||
miR-3610 | x | 1 | |||
miR-4282 | x | 1 | |||
miR-4286 | x | 1 | |||
miR-452-3p | x | 1 | |||
miR-516a-3p | x | 1 | |||
miR-572 | x | 1 | |||
miR-625-5p | x | 1 | |||
miR-122-5p | x | 1 | |||
miR-181c-3p | x | 1 | |||
miR-30a-5p | x | 1 | |||
miR-3615 | x | 1 | |||
miR-3680-3p | x | 1 | |||
miR-375 | x | 1 | |||
miR-378a-5p | x | 1 | |||
miR-589-3p | x | 1 | |||
miR-665 | x | 1 |
For each microRNA contained in any of the resampling signatures, the signatures in which the miRNA is included are marked. The table is sorted in the decreasing order of the number of signatures contained.